Flumatinib blocks the activity of platelet-derived growth factor receptors (PDGFR), which play a crucial role in cell growth, angiogenesis, and tissue.
Molecular Weight
562.59
Molecular Formula
C29H29F3N8O
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Flumatinib is used as a PDGFR inhibitor in studies exploring platelet-derived growth factor receptor-associated cancer therapies.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
